课题基金 / 基金详情

Organic Chemical Creation of Substances with Novel Function and Its Application

Organic Chemical Creation of Substances with Novel Function and Its Application
有机化学合成新功能物质及其应用
批准号:
12672065
负责人:
TAKAYAMA Hiroaki
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TAKAYAMA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The heading numbers are same as those described in 2000〜2001 research projects.(1) Studies on solitary wasp venoms have been postponed due tithe urgency in the studies on A-ring modified vitamin D analogues.2-1) All eight possible A-ring diastereomers of 2-methyl-1, 25-dihydroxyvitamin D_3 and their 20-epimers were convergently synthesized by Trost's Pd coupling reaction of A-ring precursors enynes with CD ring portions. The synthesized analogues were biologically evaluated both in vitro and in vivo. The potency was highly dependent on the stereochemistry of each isomer. In particular, 2α-Me-1α,25-(OH)_2D_3 exhibited 4-fold higher potency than 1α,25(OH)_2D_3 (natural hormone) (1) both in VDR (Vitamin D Receptor) binding and in elevation of rat serum calcium concentration and was twice as potent as 1 in HL-60 cell differentiation. Furthermore, 20-epi-2α-Me-1α,25-(OH)_2D_3, exhibited exceptionally high activities : 12-fold higher in VDR binding affinity, 7-fold higher in calcium mobiliza … More tion, and 590-fold higher in HL-60 cell differentiation, as compared to 1. Conformational analysis of the A-ring of eight diastereomers by ^1H-NMR and molecular mechanics calculation (MM2^*) were carried out : α-form (60:40) was predominant over β-form in 2α-Me analogue, β-form was predominant over α-form(75:25) in 2β-Me analogue. On the other hand, α-ring in 2α-Me-1 α,25-(OH)_2D_3 existed exclusively in the β-form by an X-ray crystallographic analysis. These findings did not permit any decisive conclusion to the well-known hypothesis "the A-ring of natural hormone equilibrates between two chair conformers, the α-form and β-form (1:1) and the β-form , in which the 1 α-OH occupies the equatorial position, may be responsible for biological activity". In further evaluation of biological activities, we found that the structural requirement for inducing apoptosis of HL-60 ells was clearly different from that for inducing differentiation of these cells. Therefore, these findings provided useful information not only for structure-function studies of 1α,25(OH)2_D_3 analogues but also the development of therapeutic agents for the treatment of leukemia and other cancers.2-2) In connection with 19-nor-lα 2b(OH)_2D_3 analogue as a candidate for cancer therapy all possible A-ring stereoisomers of 5, 6-trans-2-methyl-1, 25-(OH)_2D_3 and their 20-epimers were synthesized and biologically evaluated. Introduction of the pseudo 2α-Me to 5, 6-trans-1, 25- (OH)_2D_3 enhanced the potency. Based on Moras's X-ray structure of the complex of 1 with VDR, computational docking studies of 2α-Me-analogues to VDR by molecular mechanics calculation revealed the activity-strengthening effect of 2α-Me group.2-3) In order to investigate the activity-strengthening effect of 2α-Me group, 2α-alkyl, 2α-(ω-hydroxyalkyl), and 2α-(co-hydroxyalkoxy)- 1α,25(OH)_2D_3 analogues were convergently synthesized by Pd-coupling reactions of CD ring portion with A-ring precursors enynes, which were stereoselectively synthesized starting from sugars, and then biologically evaluated. 2α-hydroxypropyl analogue exhibited 3-fold higher potency than in VDR binding , 2.4 fold higher in HL-60 cell differentiation, and surprisingly 508-fold higher in Ca mobilization, as compared to 1. 2α hydroxybutyl- and 2α-hydroxypropoxy-analogues also showed higher VDR binding affinity than 1. Computational docking studies of three analogues to VDR revealed the activity-strengthening effect of these group.3) New synthetic route to A-ring precursor in convergent synthesis of 1α,25-(OH)_2D_3analogues was developed starting from furansulfolene. Less
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Katsuhiro Konno: "Synthesis, biological evaluation, and conformational analysis of A-ring Diastereomers of 2-methyl-1,25-dihydroxyvitamin D_3 and their 20-epimers"J.Med.Chem.. 43. 4247-4265 (2000)
Katsuhiro Konno:“2-甲基-1,25-二羟基维生素 D_3 的 A 环非对映异构体及其 20-差向异构体的合成、生物学评价和构象分析”J.Med.Chem.. 43. 4247-4265 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshitomo Suhara: "Syntheses and biological evaluation of novel 2α-substituted-1α, 25-dihydroxyvifamin D_3 analogues"Bioolrg, & Med. Chem. Letters.. 10. 1129-1132 (2000)
Yoshitomo Suhara:“新型 2α-取代-1α, 25-二羟基维生素 D_3 类似物的合成和生物学评价”Bioolrg, & Med Letters.. 10. 1129-1132 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Akihiro Yoshida: "Regioselective cleavage of the cyclic ethereal bond of 7-oxabicyclo [2. 2. 1] heptane derivatives mediated samarium (II) iodide"Tetrahedron Letters. 42. 3603-3606 (2001)
Akihiro Yoshida:“7-氧杂双环[2.2.1]庚烷衍生物介导的碘化钐(II)环醚键的区域选择性裂解”四面体快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toshie Fujishima: "Highly potent cell differentiation-inducing analogues of 1α,25-dihydroxyvitamin D_3: Synthesis and biological activity of 2-methyl-1 ,25-dihydroxyvitamin D_3 with side chain modifications."GiBioorg. Med. Chem.. 9. 525-535 (2001)
Toshie Fujishima:“1α,25-二羟基维生素 D_3 的高效细胞分化诱导类似物:具有侧链修饰的 2-甲基-1,25-二羟基维生素 D_3 的合成和生物活性。”GiBioorg Med.. 9. 525 -535 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
33
    Organic Chemical Investigation of Novel Biologically Active Compounds, Syntheses and Reactions, Evaluation of Biological Activities.
    • 批准号:
      09672161
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      1997
    • 负责人:
      TAKAYAMA Hiroaki
    • 依托单位:
    Studies on the reactions of 3-sulfolenes and their application to the Synthesis of ph-siologically active compounds.
    海外基金